mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |